Hydroxyzin Bluefish

Hydroxyzine, the active ingredient in Hydroxyzin Bluefish, is a first‑generation antihistamine presented as an oral dosage form for oral use. Approved in the European Union, it is employed to relieve allergic skin reactions, itching, anxiety and to provide sedation in adult patients.

GNH USA supplies Hydroxyzin Bluefish as a licensed, GDP‑compliant international pharmaceutical supplier, providing the product to hospitals, pharmacies and clinics worldwide under strict quality standards. The company ensures compliance with EU pharmaceutical regulations and maintains cold‑chain logistics where required.

Hydroxyzine is a first‑generation antihistamine that acts on histamine‑mediated conditions.

Allergic skin conditions: reduces redness, swelling and itching associated with urticaria or dermatitis. Pruritus: alleviates generalized itching caused by various dermatologic disorders. Anxiety: provides short‑term relief of tension and nervousness in adults. Sedation: induces calming effects useful before medical procedures or for insomnia adjunct.

Hydroxyzine may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Drowsiness: feeling of sleepiness or reduced alertness. - Dry mouth: decreased salivation leading to thirst. - Dizziness: light‑headed sensation, especially when standing quickly. - Blurred vision: temporary visual disturbances. - Constipation: reduced bowel movements. - Headache: mild to moderate head pain. - Nausea: feeling of stomach upset.

Serious or Rare Side Effects: - Cardiac arrhythmia: irregular heart rhythm requiring medical attention. - Severe allergic reaction: rash, swelling, or difficulty breathing (anaphylaxis). - Hepatotoxicity: signs of liver injury such as jaundice or elevated enzymes.

When prescribing hydroxyzine, several precautions should be observed to minimize risk.

- Assess renal and hepatic function: adjust use in patients with severe impairment. - Avoid use in the elderly: increased susceptibility to sedation and falls. - Caution with CNS depressants: concurrent use may enhance drowsiness. - Monitor for QT prolongation: consider ECG in patients with cardiac risk. - Pregnancy and lactation: use only if benefit outweighs potential risk (category unknown). - Store at room temperature: keep in original container, protect from moisture and light.

Hydroxyzine can interact with other medicines, altering its effects or safety profile.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): risk of severe hypotension and sedation. - CNS depressants (e.g., benzodiazepines, opioids): additive sedation and respiratory depression. - Anticholinergic agents (e.g., atropine): heightened anticholinergic toxicity.

Moderate Interactions (Monitor Closely): - CYP3A4 inhibitors (e.g., erythromycin, ketoconazole): may increase hydroxyzine plasma levels. - Alcohol: can potentiate drowsiness and impair coordination. - QT‑prolonging drugs (e.g., quinidine): may increase risk of cardiac arrhythmias.